AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DOCETAXEL
95 registrations across 10 African markets— 66 active
Markets with DOCETAXEL
🇿🇦South Africa
35 registrations
27 active
🇹🇳Tunisia
16 registrations
0 active
🇲🇦Morocco
13 registrations
13 active
🇸🇳Senegal
8 registrations
8 active
🇿🇼Zimbabwe
6 registrations
6 active
🇬🇭Ghana
6 registrations
6 active
🇹🇿Tanzania
5 registrations
5 active
🇨🇮Côte d'Ivoire
3 registrations
0 active
🇲🇼Malawi
2 registrations
0 active
🇷🇼Rwanda
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DOCETAXEL INJECTION | 🇬🇭Ghana | — | active | Feb 2030 |
| DOCETAXEL INJECTION | 🇬🇭Ghana | — | active | Feb 2030 |
| DOCETAXEL IMPACT Solution for injection | 🇷🇼Rwanda | SANOFI-AVENTIS DEUTSCHLAND GmbH | active | Aug 2029 |
| HODEXEL 20 mg/ml | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2029 |
| HODEXEL 80 mg/4 ml | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2029 |
| HODEXEL 160 mg/8 ml | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2029 |
| DOCETAXEL 80 mg/4 ml HETERO | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2029 |
| DOCETAXEL 160 mg/8 ml HETERO | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2029 |
| DOCETAXEL 20 mg/ml HETERO | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2029 |
| OTAXEC 20 mg/2 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2029 |
| OTAXEC 160 mg/16 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2029 |
| CEDOCET 80 mg/8 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2029 |
| CEDOCET 20 mg/2 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2029 |
| CEDOCET 160 mg/16 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2029 |
| OTAXEC 80 mg/8 ml | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2029 |
| DOXOL 80 SOLUTION | 🇿🇼Zimbabwe | VENUS REMEDIES LTD | active | Feb 2029 |
| DOCETAXEL MYLAN INJECTABLE; INJECTION | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED (OTL) | active | Dec 2027 |
| DOCETAXEL MYLAN INJECTABLE; INJECTION | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED (OTL) | active | Dec 2027 |
| AVADOC 120 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS LTD | active | Dec 2027 |
| AVADOC 20 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS LTD | active | Dec 2027 |
| AVADOC 80 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS LTD | active | Dec 2027 |
| DOCETAXEL CONCENTRATE FOR SOLUTION FOR INFUSION (Each vial contains Docetaxel 10mg/ml) | 🇬🇭Ghana | — | active | Dec 2026 |
| DOCETAXEL CONCENTRATE FOR SOLUTION FOR INFUSION (Each vial contains Docetaxel 10mg/ml) | 🇬🇭Ghana | — | active | Dec 2026 |
| TAXOTERE SOLUTION FOR INFUSION | 🇬🇭Ghana | — | active | Nov 2026 |
| TAXOTERE SOLUTION FOR INFUSION | 🇬🇭Ghana | — | active | Nov 2026 |
| DOCELEX 20 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| DOCELEX 80 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| ACCORD DOCETAXEL 80 | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | suspended | Jun 2025 |
| ACCORD DOCETAXEL 20 | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | suspended | Jun 2025 |
| DOCETERE 80 mg/4 ml RTU | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | May 2025 |
| DOCETERE 20 mg/1 ml RTU | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | May 2025 |
| KEY-DOCETAXEL 80 mg AND DILUENT SOLUTION | 🇿🇦South Africa | Key Oncologics (Pty) Ltd | suspended | May 2025 |
| KEY-DOCETAXEL 20 mg AND DILUENT SOLUTION | 🇿🇦South Africa | Key Oncologics (Pty) Ltd | suspended | May 2025 |
| DOCETAXEL 80MG/8ML CONCENTRATE SOLUTION FOR INFUSION CONCENTRATE SOLUTION FOR INFUSION | 🇲🇼Malawi | — | expired | Mar 2024 |
| DOCETAXEL 20MG/2ML CONCNTRATE FOR SOLUTION FOR INJECTION CONCNTRATE FOR SOLUTION FOR INJECTION | 🇲🇼Malawi | — | expired | Mar 2024 |
| TAXOTERE 80MG/4ML SOLUTION A DILUER POUR PERFUSION FLACON DE 4ML | 🇨🇮Côte d'Ivoire | SANOFI MATURE IP, PARIS, 54 RUE LA BOETIE | expired | Aug 2022 |
| TAXOTERE 20MG/4ML SOLUTION A DILUER POUR PERFUSION FLACON DE 4ML | 🇨🇮Côte d'Ivoire | SANOFI MATURE IP, PARIS, 54 RUE LA BOETIE | expired | Aug 2022 |
| DOCETAXEL 2OMG/ML SOLUTION INJECTABLE FLACON DE 10 FLACONS DE 1ML | 🇨🇮Côte d'Ivoire | BIOLYSE PHARMA CORPORATION | expired | Jan 2021 |
| DOCETAXEL NEAPOLIS Solution injectable pour perfusion / 20 mg/ml | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Sept 2020 |
| DOCETAXEL NEAPOLIS Solution injectable pour perfusion / 80 mg/4 ml | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Sept 2020 |
| DOCETAXEL AQVIDA Solution injectable pour perfusion / 20 mg/ml (80mg/4ml) | 🇹🇳Tunisia | AQVIDA GMBH | expired | Aug 2019 |
| DOCETAXEL AQVIDA Solution injectable pour perfusion / 20 mg/ml | 🇹🇳Tunisia | AQVIDA GMBH | expired | Aug 2019 |
| DOCETAXEL KABI Solution injectable pour perfusion / 20 MG | 🇹🇳Tunisia | FRESENIUS KABI ONCOLOGY PLC | expired | Jun 2017 |
| DOCETAXEL KABI Solution injectable pour perfusion / 80 MG/4ML | 🇹🇳Tunisia | FRESENIUS KABI ONCOLOGY PLC | expired | Jun 2017 |
| DOCETAXEL ACCORD Solution injectable pour perfusion / 80 mg | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Jul 2016 |
| DOCETAXEL ACCORD Solution injectable pour perfusion / 20 mg | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Jul 2016 |
| CYTOTERE Solution injectable pour perfusion / 80 mg / 4 ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Jul 2016 |
| CYTOTERE Solution injectable pour perfusion / 20 mg/ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Jul 2016 |
| EBEDOCE 20 MG/2ML Solution injectable pour perfusion / 10 mg/ ml | 🇹🇳Tunisia | EBEWE Pharma | expired | Jul 2011 |
| EBEDOCE 80 MG/8ML Solution injectable pour perfusion / 10 mg/ ml | 🇹🇳Tunisia | EBEWE Pharma | expired | Jul 2011 |
Showing 50 of 95 registrations. Sign up free to search and export all.
DOCETAXEL in Africa — Regulatory Overview
DOCETAXEL is registered across 10 African markets with 95 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Morocco, Senegal and 6 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 95 registrations, 66 (69%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.